| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net loss | -42,152 | -93,800 | ||
| Basic earnings (loss) per common share | -0.16 | -0.39 | ||
| Diluted earnings (loss) per common share | -0.16 | -0.39 | ||
| Weighted-average number of common shares - basic | 260,494,000 | 238,409,000 | ||
| Weighted-average number of common shares - diluted | 260,494,000 | 238,409,000 | ||
Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA)